Future Proofing & Incentives Among Industry Priorities In EU Pharma Law Shake Up
Overhaul of the pharmaceutical legislation in the EU is an opportunity to learn from COVID-19, says European industry body.

Overhaul of the pharmaceutical legislation in the EU is an opportunity to learn from COVID-19, says European industry body.